Rise in prevalence of target chronic diseases like cancer, increase in unhealthy lifestyle habits, mergers and acquisitions by major companies, product launches, the development of biologics with higher efficiency and favorable research funding scenario are key factors contributing to high CAGR of Biologics during forecast period.
Rise in prevalence of target chronic diseases like cancer, increase in unhealthy lifestyle habits, mergers and acquisitions by major companies, product launches, the development of biologics with higher efficiency and favorable research funding scenario are key factors contributing to high CAGR of Biologics during forecast period.
According to the current analysis of Reports and Data, the global Biologics market was valued at 324.78 Billion in 2020 and is expected to reach 749.62 Billion by 2028, at a CAGR of 10.80%. The study covers Biologics, a drug that contains living organisms or their specific components or by-products. Biologic medicines are usually injected into the patient’s body because of its large molecular size (200-1000x) and fragile molecular structure. Parts of organisms like their cells, tissues, recombinant proteins, genes, allergens, blood or blood components, and vaccines are used in biologic drugs. Biologics are used for the treatment of various diseases and conditions like anemia, cancer, and other autoimmune diseases. Biologics are changing the ways doctors treat common conditions that have plagued individuals for years. Biologics have various potential advantages as they can, theoretically, be customized to hit specific ‘gene targets’ in the human body
AbbVie’s Humira (adalimumab) – a drug used to treat autoimmune disorders such as rheumatoid arthritis. Biologics products including those which are manufactured by biotechnology are heat sensitive and susceptible to contamination. Hence, it is essential to maintain aseptic condition from initial manufacturing process till the end of the production, Biologic drugs have witnessed a significant success rate, notably in cancer and autoimmune diseases. The new developments in the field of immunotherapies, gene and cell therapies, and antibody-drug conjugates, will contribute to the expected growth of biologics in the next upcoming future. Biologics are mostly to continue their growth trend with more innovative technologies and therapies coming to the market. In some therapeutic areas treatment with biologic is quite significant, especially in high-income countries. The momentum of new biologic launches is likely to continue for some time into the future. Rise in prevalence of target chronic diseases such as cancer, increase in unhealthy lifestyle habits, technological advancements, company agreements like mergers and acquisitions by key players, government support and initiative for development and implementation of biologics, collaboration of global leading companies, more companies earning market approval, product launches, the development of biologics with higher efficiency and scope, and a favorable research funding scenario are key factors contributing to high CAGR of Biologics during forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2030
Biologics provide safer solutions in many areas of unmet medical demands, and their growth is expected to continue. Moreover, Biological products represent the cutting edge of technological innovation of technology and bio medical research and may offer the effective ways to treat diverse medical illness and ailments that presently have no other alternative treatment. Nevertheless, their high cost, patent cliff, a strict regulatory environment, and the emergence of alternative solutions, limited scope of treatment pose challenges. However, stringent government regulations and associated side effects such as gastrointestinal complications, change in blood pressure, chest pain, breathing problems, etc. is expected to hamper the market and found to be the major hindrance for market growth during 2019-2026.
Further key findings from the report suggest
- Biologics market is growing at a CAGR of 13.0% in Asia Pacific followed by North America and Europe, with 11.8% and 11.6% CAGR, respectively. Rise in prevalence of cancer and other target diseases across the globe is the key factor to accelerate the market growth during forecast period across all regions.
- As of 2018, Monoclonal Antibodies segment dominates the market holding 39.0% of the global market since it is the primary medicine used for the treatment of cancer.
- On the basis of product type, Gene biologics are growing predominantly with a CAGR of 14.3% followed by vaccines and cellular biologics.
- On the basis of application, Cancer is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 12.4%.The key factor responsible for the growth of the segment is predominant rise in cancer and geriatric population worldwide.
- Cancer application segment holds a market share of 42.2% followed by autoimmune diseases and infectious diseases holding 35.9% and 14.6% respectively.
- Asia Pacific is expected to account for the 21.4% of the global Biologics market due to the large prevalence of target diseases in countries like India and China.
- Stringent government regulations and associated side effects like gastrointestinal complications, change in blood pressure, chest pain, breathing problems etc. are the key challenges faced by the Biologics market players.
- Key participants include Merck & Co. Inc., AbbVie, Inc., AstraZeneca Plc., Amgen, Inc., Bristol-Myers Squibb Co., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., GlaxoSmithKline Plc., Novartis AG, Pfizer, Inc., and Novo Nordisk A/S
Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/biologics-market
For the purpose of this report, Reports and Data has segmented the Biologics market on the basis of product, application, end use and region:
Product type Outlook (Revenue, USD Million; 2016-2026)
- Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cellular Based Biologics
- Gene Based Biologics
Application Outlook (Revenue, USD Million; 2016-2026)
- Cancer
- Infectious Diseases
- Autoimmune diseases
- Others
End use Outlook (Revenue, USD Million; 2016-2026)
- Hospitals
- Clinics
- Diagnostic Centers
- Others
Buy Premium Research Report @ https://www.reportsanddata.com/report-pricing/2030
Regional Outlook (Revenue, USD Million; 2016-2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2030
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Automated Microbiology Market By Product (Instruments, Automated culture systems, Microbiology analyzers, Reagents), By Diagnostics Technology (DNA & RNA probe technology, DNA sequencing, Detection Techniques, Immunoassays, Monoclonal Antibodies), By End-Use (Clinical Laboratories, Biotechnology Industries, Others), and By Region Forecast to 2028
Infrared Imaging Market By Product (Near-infrared Fluorescence Imaging Systems, Near-Infrared Fluorescence And Bioluminescence Imaging Systems), By wavelength (Near Infrared, Shortwave Infrared, Mid-Wave Infrared, Long-Wave Infrared), By Application (Health Monitoring and Inspection, Security and Surveillance, Detection), and By Region Forecast to 2028
Vascular Imaging Market By Procedure (Coronary Angiography, Peripheral Angiography, and Others), By Technology (Magnetic Resonance Angiography, Computed Tomography Angiography, and Others), By Application (Diagnostic, Therapeutic), By End-use (Hospitals, Diagnostic Imaging Centers, Others), and By Region Forecast to 2028
Trauma Products Market By Type (External Fixators, Internal Fixators), By Surgical Site (Lower Extremities, Upper Extremities), By End-Use (Hospitals & Trauma Centers, Ambulatory Surgery Center), and By Region Forecast to 2028
ENT Medical Devices Market By Product (Diagnostic Devices (Endoscope and Hearing Screening Devices), Surgical Devices (Powered Surgical Instruments, ENT Supplies, and Ear Tubes), Hearing Aids, CO2 Lasers, and Others), By End-Use (Home Care Settings, Hospital & Ambulatory Settings, ENT Clinics, and Others), And By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-biologics-market